Skip to main content
logo
MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
3.190
+0.070 (2.24%)
Aug 21, 2026, 5:35 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
60771118179132
Market Cap Growth
-34.52%-29.96%36.57%2.32%-40.01%-
Enterprise Value
5377975949123
Last Close Price
3.194.817.966.988.0013.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.2917.1234.3936.3555.35135.75
PB Ratio
33.4143.0610.703.962.953.31
P/TBV Ratio
--12.914.243.093.38

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.6516.9830.0526.4134.22126.09

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
9.699.691.540.690.420.15
Net Debt / Equity Ratio
-4.13-4.13-0.41-0.50-0.89-0.94
Net Debt / EBITDA Ratio
0.250.250.150.521.804.30
Net Debt / FCF Ratio
0.460.460.180.521.814.59
Asset Turnover
0.110.110.080.050.030.03
Inventory Turnover
23.3523.3512.717.4116.05-
Quick Ratio
1.871.871.812.654.389.93
Current Ratio
1.941.941.902.784.5710.05
Return on Equity (ROE)
-511.92%-511.92%-187.68%-83.41%-41.14%-32.33%
Return on Assets (ROA)
-44.75%-44.75%-43.64%-28.44%-18.00%-15.08%
Return on Capital Employed (ROCE)
-107.80%-107.80%-118.70%-63.50%-38.20%-19.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-51.67%-40.10%-26.13%-24.34%-17.32%-6.83%
FCF Yield
-27.16%-21.07%-20.61%-24.40%-16.76%-6.19%
Buyback Yield / Dilution
-21.97%-21.97%-14.95%-14.89%-307.65%-135.06%